Hua Medicine (Shanghai) Ltd.

Hua Medicine (Shanghai) Ltd.verified

HUMDF

Price:

$0.3401

Market Cap:

$1.85B

Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known as HMS5552), an oral medication currently being developed for managing Type 2 Diabetes (T2D). Additionally, the company is advancing Dorzagliatin through Phase I clinical trials when combined with Metformin, Sitagliptin, and Empagliflozin, also for T2D therapy. Dorzagliatin's potential extends to other applications, including combinations with Pioglitazone for NASH, with GLP-1 for Alzheimer's disease, and for the management of both late-stage Type 2 and Type 1 Diabetes. Furthermore, Hua Medicine ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-03-15

Stock Exchange

OTC

Ticker

HUMDF

The PE Ratio as of June 2026 (TTM) for Hua Medicine (Shanghai) Ltd. (HUMDF) is 2.13

According to Hua Medicine (Shanghai) Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 2.13. This represents a change of -158.45% compared to the average of -3.64 of the last 4 quarters.

Hua Medicine (Shanghai) Ltd. (HUMDF) Historical PE Ratio (quarterly & annually)

How has HUMDF PE Ratio performed in the past?

The mean historical PE Ratio of Hua Medicine (Shanghai) Ltd. over the last ten years is -10.61. The current 2.13 PE Ratio has changed -2107.36% with respect to the historical average. Over the past ten years (40 quarters), HUMDF's PE Ratio was at its highest in in the June 2025 quarter at 0.54. The PE Ratio was at its lowest in in the December 2017 quarter at -37.81.

Quarterly (TTM)
Annual

Average

-10.61

Median

-9.39

Minimum

-26.58

Maximum

2.54

Hua Medicine (Shanghai) Ltd. (HUMDF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hua Medicine (Shanghai) Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.26%

Maximum Annual PE Ratio = 2.54

Minimum Annual Increase = -147.15%

Minimum Annual PE Ratio = -26.58

Quarterly (TTM)
Annual
YearPE RatioChange
20252.54-147.15%
2024-5.38-34.84%
2023-8.26-47.30%
2022-15.6775.45%
2021-8.93-23.54%
2020-11.6818.54%
2019-9.851.26%
2018-0.72-97.28%
2017-26.5823.21%

Hua Medicine (Shanghai) Ltd. (HUMDF) Average PE Ratio

How has HUMDF PE Ratio performed in the past?

The current PE Ratio of Hua Medicine (Shanghai) Ltd. (HUMDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.70

5-year avg

-7.14

10-year avg

-10.61

Hua Medicine (Shanghai) Ltd. (HUMDF) PE Ratio vs. Peers

How is HUMDF’s PE Ratio compared to its peers?

Hua Medicine (Shanghai) Ltd.’s PE Ratio is greater than Allergy Therapeutics plc (-8.00), less than Knight Therapeutics Inc. (163.04), less than Boiron S.A. (14.97), greater than Cresco Labs Inc. (-2.19), greater than PureTech Health plc (-3.81), less than Clinuvel Pharmaceuticals Limited (15.07), greater than Hansa Biopharma AB (publ) (-4.74), greater than Nika Pharmaceuticals Inc. (-6959.20), greater than Verano Holdings Corp. (-1.56), less than Ion Beam Applications S.A. (37.39),

Build a custom stock screener for Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hua Medicine (Shanghai) Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hua Medicine (Shanghai) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Hua Medicine (Shanghai) Ltd.'s PE Ratio?

How is the PE Ratio calculated for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the highest PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the 3-year average PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the 5-year average PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

How does the current PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF) compare to its historical average?